Skip to main content

Tagged With "Trelegy Ellipta"

Blog Post

Will Your Asthma and Allergy Drugs Still Be on Your Insurance Plan in 2017?

AAFA Community Services ·
Two prescription benefit managers are dropping certain asthma and allergy drugs from their formularies in 2017. If you take these medicines and have your prescriptions covered by CVS Caremark or Express Scripts, other medicines will be substituted instead.
Blog Post

Trelegy Ellipta Inhaler Is Now Approved for Asthma Treatment

AAFA Community Services ·
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to its current license for use in patients with chronic obstructive pulmonary disease (COPD). Trelegy Ellipta is not indicated for relief of acute bronchospasm.
Blog Post Featured

Asthma Diagnosis, Management, and Treatment in the U.S. Is Changing – What the New Guidelines Say

AAFA Community Services ·
On Dec. 3, 2020, the National Institutes of Health (NIH) announced updates to the clinical guidelines used to diagnose and manage asthma. The new guidelines are titled "The 2020 Focused Updates to the Asthma Management Guidelines: A Report from The National Asthma Education and Prevention Program Expert Panel Working Group." The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, oversaw the National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) and...
×
×
×
×